1. Introduction {#s0005}
===============

Evidence has accumulated to indicate that heat shock protein 72 (HSP72) promotes cell survival under various pathologic conditions by interacting with multiple components of caspase-dependent and -independent apoptotic pathways [@b0005]. Exogenous HSP72 overexpression significantly reduced cerebral ischemia-induced neuronal loss in rats [@b0010]. In contrast, knockout of HSP72 exacerbated infact volume in mice after focal cerebral ischemia [@b0015]. These findings suggest that HSP72 has significant neuroprotective effects across multiple models of brain ischemia.

According to the description by Wang et al. [@b0020], HSP27 may play a role in the response of patients to heat stroke. Many of the heatstroke patients, displayed decreased serum levels of HSP72. The decreased response was more pronounced in those with serious heatstroke than in those with mild heatstroke. Evidence has accumulated to indicate that decreased heat tolerance is associated with hypothalamic impairment [@b0025]. Thermal injury to the hypothalamus has been hypothesized to be the primary mechanism of multiple organ failure and mortality [@b0030; @b0035]. To our knowledge, evidence is not available whether cellular levels of HSP in the hypothalamus play a role in heat-induced cell death.

The present study was performed to investigate whether heat-induced cell death in rat primary cultured hypothalamic cells can be attenuated or exacerbated by increasing or decreasing HSP72, respectively. The cellular levels of HSP72 were elevated by mild heat preconditioning (MHP) [@b0040; @b0045; @b0050] or lowered by gene silencing [@b0055; @b0060].

2. Materials and methods {#s0010}
========================

2.1. Ethics statement {#s0015}
---------------------

All animal procedures were performed in accordance to the guideline of the Ministry of Science and Technology of the Republic of China (Taipei, Taiwan) for Animal Care and approved by the Chi Mei Medical Center Animal Care Committee (protocol no: 100/20751). Animals were housed in specific pathogen-free facilities at the Chi Mei Medical Center (Tainan, Taiwan). All surgery was performed under anesthesia using isoflurane, and all efforts were made to minimize suffering. Human euthanasia of rats was performed by carbon dioxide with a flow rate of 20% of chamber volume/min following the guidelines of the Ministry of Science and Technology of the Republic of China.

2.2. Construction of recombinant pSUPER plasmid expressing HSP72 siRNA {#s0020}
----------------------------------------------------------------------

pSUPER vector (vector) (Oligo Engine, Seattle, WA, USA), which contains polymerase-III HI-RNA gene promoter, can direct the synthesis of siRNA-like transcripts. The target sequence for HSP72 (Gen Bank Accession No. NM_031971) was chemically synthesised (Tri-1 Biotech; Taipei, Taiwan) as complementary oligonucleotides [@b0055]. ABLAST (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>) search of the human genome database was done to ensure that the sequence did not target other gene transcripts. The synthetic oligonucleotide siRNA-HSP72: 5′-GATCCCC**GGAGATCATCGCCAACGAC**TTCAAGAGA**GTCGTTGGCGATGATCTCC**TTTTTA-3′ and 3′-GGG**CCTCTAGTAGCGGTTGCTG** AAGTTCTCT**CAGCAACCGCTACTAGAGG**AAAAATTCGA-5′ was annealed and cloned downstream of HI promoter to construct recombinant pSUPER/siRNA-HSP72 plasmid (siRNA-HSP72). The cloned HSP72 target sequence was sequence-confirmed using a DNA sequencer (ABI Prism 377; Applied Biosystems, Foster City, CA, USA).

2.3. Cell culture and stable transfection {#s0025}
-----------------------------------------

Primary cultured hypothalamic cells were obtained from embryonic (E18d) Sprague--Dawley rat fetuses. Briefly, the brains were removed and the hypothalamus were dissected out. The tissues were cut into fragments, and incubated in 0.2% trypsin for 20 min in 37 °C. Then, DMEM medium (Hyclone, Waltham, MA, USA) containing 10% fetal bovine serum (Hyclone) was added for trypsin activation, and the tissues were dissociated by mild mechanical trituration. About 1 × 10^5^ cells in 1 mL were plated onto poly-[d]{.smallcaps}-lysine-coated 6-well plates for further culture. After 4 h, the DMEM medium was changed into Neurobasal™ medium (Gibco, Carlsbad, CA, USA) supplemented with 2% B-27 serum-free supplement (Gibco) and 0.5 mM [l]{.smallcaps}-glutamine in a humidified incubator containing 95% air and 5% CO~2~ at 37 °C. Primary cell cultures were maintained for 8 days before experiments. Eight hours before hyperthermic injury, cells were transfected with pSUPER/siHSP72 plasmid and with pSUPER vector as control by using oligofectamine transfection according to the manufacturer's instruction. The positive clones were picked and expanded to establish cell lines, and stable transfection cell lines expressing HSP72 siRNA were determined by Western blot analysis.

2.4. Western blot analysis {#s0030}
--------------------------

The cells were harvested from flasks, and lysed in a lysis buffer (50 mM Tris, pH 7.4, 100 mM NaCl, 1 mM MgCl~2~, 2.5 mM VO~4~, 1 mM PMSF, 2.5 mM EDTA, 0.5% Triton X-100, 0.5% NP-40, 5 μg/mL of aprotonin, peptatin A, and leupeptin) for 60 min. Protein samples (500 μg) were separated on 10% or 12% SDS--PAGE gels, and transferred to Hybond-P PVDF membranes (Amersham Biosciences, Stockholm, Sweden). After blocking with 5% non-fat dry mild in TBS-T buffer (20 mM Tris, pH 7.6, 100 mM NaCl, 0.1% Twn-20) for 2 h at room temperature, the membranes were probed with a 1:1000 dilution of anti-HSP72 (DO-1, Santa Cruz Biotechnology, CA, USA) overnight at 4 °C, and a 1:5000 dilution of β-actin (AC-15, Sigma--Aldrich) to correct for differences in protein loading, followed by incubation in a 1:2000 dilution of secondary antibodies conjugated to horseradish peroxidase (Amersham Biosciences) for 1 h at room temperature. Protein bands were detected using ECL detection (Amersham Biosciences). All of the Western immunoblots were performed at least three times.

2.5. Simulated hyperthermic injury (HI) model {#s0035}
---------------------------------------------

The primary hypothalamic cultured cells were put in a circulating 43 °C water bath for 120 min to induce HI, while the normothermic controls were kept in a 37 °C incubator for the equivalent time.

2.6. Mild heat preconditioning (MHP) {#s0040}
------------------------------------

Eight hours before the start of HI, the cells were kept in a circulating 42 °C water bath for 30 min to induce HSP72 expression [@b0040].

2.7. Cell viability {#s0045}
-------------------

Cell viability was determined using an MTT (3-C-4.5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay (Invitrogen, Carlsbad, CA, USA) in which the yellow tetrazolium salt catalyzed by nicotinamide adenine dinucleotide (NAD)-dependent dehydrogenase (in active mitochondria) to form purple formalin salt crystals. Cells were seeded into a 96-well plate. After HI, the MTT reagent (5 mg/mL in PBS) was added to each well and then incubated for 4 h. After the assay reagent had been removed, dimethyl sulfoxide (DMSO) was added to each well to solubilize the purple crystals. Plates were then immediately analyzed using an ELISA plate reader (Biotals Instruments, Winooski, VVT, USA) at 580 nm. Cell viability was defined relative to the ratio of normothermic control cells as follow: cell viability (%) = (value of optical density of treated sample)/(value of optical density of control × 100).

2.8. Flow cytometry {#s0050}
-------------------

Apoptosis was analyzed using a kit (Annexin V-FITC kit, Beckman Coulter, Fullerton, CA) that measures the binding of a fluorescein-labelled annexin V to phosphatidylserine residues translocated on the cell surface soon after the induction of apoptosis and before nuclear breakdown occurs. After HI, cells were collected by trypsinisation and were suspended at a concentration of 1 × 10^6^/mL in phosphate buffered saline. All subsequent steps were done on ice. The cells were resuspended in binding buffer and incubated with annexin V-FITC for 15 min in the dark. The cells were then re-pelleted and re-suspended in binding buffer, propidium iodide was added, and a flow cytometer (Beckman Coulter, Miami, FL, USA) was used for analysis: (A) viable cells do not stain with either reagent, (B) necrotic cells stain with both reagents, and (C) apoptotic cells stain with annexin V-FITC only.

2.9. Experimental groups {#s0055}
------------------------

Six groups of hypothalamic cells were used in the present study ([Fig. 1](#f0005){ref-type="fig"}): (I) no mild heat preconditioning (MHP^−^) and no hyperthermic injury (HI) (MHP^−^ + HI^−^); (II) no MHP and HI (MHP^−^ + HI^+^): the cells were kept in a circulating water bath of 43 °C for 120 min; (III) MHP^+^ + HI^+^: before the start of HI, the cells were kept in a circulating 42 °C water bath for 30 min and then allowed to recover at 37 °C for 8 h; (IV) MHP^−^ + HI^+^ + siRNA-HSP72^+^ group: the MHP^−^ cells were transfected with pSUPER/siRNA-HSP72 8 h before the start of HI; (V) MHP^+^ + HI^+^ + siRNA-vector^+^ group: the MHP^+^ cells were transfected with siRNA-vector 8 h before the start of HI; and (VI) MHP^+^ + HI^+^ + siRNA-HSP72^+^ group: the MHP^+^ cells were transfected with siRNA-HSP72 8 h before the start of HI.

2.10. Statistical analysis {#s0060}
--------------------------

All assays were independently performed three times. The data are means ± standard deviation (SD). Comparisons between groups were made using analysis of variance (ANOVA) *F* tests. Bonferroni adjusted *t*-tests were used for multiple-group comparisons, and an unpaired *t*-test was used for single comparison. Significance was set at *P* \< 0.05 (two-tailed).

3. Results {#s0065}
==========

3.1. Cellular HSP72 was lower in siRNA-HSP72-treated cultured primary hypothalamic cells {#s0070}
----------------------------------------------------------------------------------------

Western blotting was used to analyze cultured primary hypothalamic cells without mild heat preconditioning (MHP^−^). In the MHP^−^ cells treated with siRNA-HSP72 (MHP^−^ + siRNA-HSP72^+^), levels of cellular HSP72 were significantly lower than those for the MHP^−^ controls (*P* \< 0.05; [Fig. 2](#f0010){ref-type="fig"}C vs. [Fig. 2](#f0010){ref-type="fig"}A). In contrast, no differences were found in the cellular levels of HSP72 between the MHP^−^ + siRNA-vector^+^ group and the MHP^-^ control group (*P* \> 0.05, [Fig. 2](#f0010){ref-type="fig"}B vs. [Fig. 2](#f0010){ref-type="fig"}A).

3.2. Cellular HSP72 was higher in MHP-treated cultured primary hypothalamic cells under HI {#s0075}
------------------------------------------------------------------------------------------

Levers of HSP72 in the cultured MHP^−^ + HI cells were insignificantly different from MHP^−^ + HI^−^ cells (*P* \> 0.05; [Fig. 3](#f0015){ref-type="fig"}II vs. [Fig. 3](#f0015){ref-type="fig"}I). In (MHP^+^ + HI^+^) cells, levels of cellular HSP72 were significantly higher than those for the (MHP^−^ + HI) cells (*P* \< 0.01; [Fig. 3](#f0015){ref-type="fig"}III vs. [Fig. 3](#f0015){ref-type="fig"}II). However, in (MHP^−^ + HI^+^ + siRNA-HSP72) cells, levels of cellular HSP72 were significantly lower than those for the (MHP^−^ + HI^+^) cells (*P* \< 0.05; [Fig. 3](#f0015){ref-type="fig"}IV vs. [Fig. 3](#f0015){ref-type="fig"}II). Levels of HSP72 in the (MHP^+^ + HI^+^ + siRNA-HSP72), but not the (MHP^+^ + HI^+^ + siRNA-vector) cells, were significantly lower than those for the (MHP^+^ + HI^+^) cells (*P* \< 0.01; [Fig. 3](#f0015){ref-type="fig"}VI vs. III).

3.3. HI-induced cell loss was reduced by MHP^+^ but exacerbated by siRNA-HSP72 {#s0080}
------------------------------------------------------------------------------

In the (MHP^−^ + HI^+^) cells, percentages of cell viability were significantly lower than those for the (MHP^−^ + HI^−^) cells (*P* \< 0.05; [Fig. 4](#f0020){ref-type="fig"}II vs. [Fig. 4](#f0020){ref-type="fig"}I). The cell loss caused by HI was significantly reduced by MHP (*P* \< 0.05; [Fig. 4](#f0020){ref-type="fig"}III vs. [Fig. 4](#f0020){ref-type="fig"}II) but significantly exacerbated by siRNA-HSP72 preconditioning (*P* \< 0.05; [Fig. 4](#f0020){ref-type="fig"}IV vs. [Fig. 4](#f0020){ref-type="fig"}II). The beneficial effects of MHP+ in reducing HI-induced cell loss were significantly attenuated by siRNA-HSP72 (*P* \< 0.05; [Fig. 4](#f0020){ref-type="fig"}VI vs. [Fig. 4](#f0020){ref-type="fig"}III) but not by siRNA-vector (*P* \> 0.05; [Fig. 4](#f0020){ref-type="fig"}V vs. [Fig. 4](#f0020){ref-type="fig"}III).

3.4. HI-induced cell apoptosis was reduced by MHP^+^ but exacerbated by siRNA-72 {#s0085}
--------------------------------------------------------------------------------

In the (MHP^−^ + HI^+^) cells, percentages of apoptotic cells were significantly higher than those for the (MHP^−^ + HI^−^) cells (*P* \< 0.01; [Fig. 5](#f0025){ref-type="fig"}II vs. [Fig. 5](#f0025){ref-type="fig"}I). The cellular apoptosis caused by HI was significantly attenuated by MHP (*P* \< 0.05; [Fig. 5](#f0025){ref-type="fig"}III vs. [Fig. 5](#f0025){ref-type="fig"}II), but significantly exacerbated by siRNA-HSP72 preconditioning (*P* \< 0.01; [Fig. 5](#f0025){ref-type="fig"}IV vs. [Fig. 5](#f0025){ref-type="fig"}II). In addition, the beneficial effects of MHP^+^ in reducing HI-induced cell apoptosis were significantly attenuated by siRNA-HSP72 (*P* \< 0.05; [Fig. 5](#f0025){ref-type="fig"}VI vs. [Fig. 5](#f0025){ref-type="fig"}III) but not by siRNA-vector (*P* \> 0.05; [Fig. 5](#f0025){ref-type="fig"}V vs. [Fig. 5](#f0025){ref-type="fig"}III).

4. Discussion {#s0090}
=============

In the central nervous system, topical application of naked small interfering RNAs (siRNA) has been used successfully to induce gene silencing [@b0065; @b0070; @b0075]. The pSUPER RNAί system (Oligo Engine, Seattle WA, USA) efficiently and specifically downregulates gene expression [@b0055], which functionally inactivates targeted genes. Indeed, as shown in the present results, topical application of pSUPER plasmid expressing HSP72 small interfering RNAA significantly attenuates the cellular levels of HSP72 in primary cultured hypothalamic cells.

Probably, the most striking findings are that the cellular levels of HSP72 can be elevated or lowered by mild heat preconditioning (42 °C for 30 min) or gene silencing (pSUPER plasmid expressing HSP72 small interfering RNA) in rat hypothalamic cells respectively. In addition, both hypothalamic cell loss and apoptosis caused by severe heat (43 °C for 120 min) are significantly attenuated or exacerbated by increasing or decreasing HSP72 levels in primary cultured hypothalamic cells, respectively. Thus, it appears that the extent of cellular heat tolerance depends upon the cellular levels of HSP72 in the hypothalamus. Our results are supported in part by human data showing that healthy volunteers with body temperature reached or exceeded 39 °C had elevated serum HSP72 levels whereas many of the heatstroke patients failed to show elevated serum HSP72 levels [@b0020]. Owing to the patients with serious heatstroke had lower serum levels of HSP72 than did the patients with mild heatstroke, they promoted that the abnormally low serum levels of HSP72 was likely the "cause" of heatstroke. In addition, our results are consistent in part with transgenic mice data. Chen and colleagues [@b0080] report that overexpression of HSP72 in the hypothalamus significantly protects against the heat-induced hypothalamic ischemia and oxidative damage, thermoregulatory dysfunction and mortality. [l]{.smallcaps}-arginine administration to heat stressed mice [@b0085] or glutamine administration to heat stressed rats [@b0090] is also shown to increase the expression of HSP72 and contributes to the protective effect of these drugs in rodents subjected to heatstroke. Geranylgeranyl-acetone, an acryclic isoprenoid, is a non-tonic inducer of HSP72, preconditioning attenuated heat-induced inflammation and multiple organ dysfunction in rats [@b0095]. Pre-induction of HSP72 in different organs (including brain) with progressive exercise [@b0100; @b0105] or hypobaric hypoxia [@b0110] preconditioning attenuates heat-induced multiple organ dysfunction in rats. A number of studies have also demonstrated that ischemic preconditioning induces neuroprotection by inducing HSP72 in neurons [@b0115]. In addition, inducing HSP72 in brain by physical exercise is shown to protect against ischemic stroke in rats [@b0120]. These observations indicate that the increased HSP72 levels prior to stress-induced injury may be one of the key issues. Increased or decreased HSP72 levels might attenuate or exacerbated the stress-induced injury, respectively.

In heat stressed animals, their hypothalami are fully activated, as suggested by the increase in c-fos mRNA and protein in different brain regions including the hypothalamus [@b0125]. The hypothalamo--pituitary--adrenocortical (HPA) axis is also mobilized as suggested by the increase in fos-positive cells [@b0130] in the hypothalamus and the increase in blood adrenocorticotropic-hormone (ACTH) and corticosterone concentrations [@b0135; @b0140]. Inter-individual heterogeneousness in heat tolerance could be associated with HPA axis activation states. In other words, the heat intolerant animals would display an inadequate HPA axis mobilization, whereas heat tolerant animals would benefit from an adequate HPA axis control [@b0025]. It is not known whether hypothalamic levels of HSP72 are associated with HPA axis activity.

Although Annexin is indeed for apoptosis, PI also marks apoptotic cells [@b0145]. This is evident in our present results in [Figs. 4 and 5](#f0020 f0025){ref-type="fig"} (viability and apoptotic). If viability is viewed as the inverse of cell death, then [Figs. 4 and 5](#f0020 f0025){ref-type="fig"} are virtually identical. That is, 100% viability in control conditions of [Fig. 4](#f0020){ref-type="fig"} is basically no apoptotic cells in control condition of [Fig. 5](#f0025){ref-type="fig"}. Similarly, 50% viability for HI + HSP72 knockdown in [Fig. 4](#f0020){ref-type="fig"} is nearly same as 50% apoptotic for same treatment in [Fig.5](#f0025){ref-type="fig"}. Based on the present data, we estimate that total dead cells (60% in [Fig. 4](#f0020){ref-type="fig"}) minus apoptotic of [Fig. 5](#f0025){ref-type="fig"} (20%) equals 40% of necrotic cells, e.g. for treatment II.

In summary, our data show that severe heat caused hypothalamic apoptosis and injury. Mild heat preconditioning, in addition to inducing HSP72 overexpression, significantly reduces severe heat shock-induced hypothalamic cell apoptosis and injury. In contrast, pSUPER plasmid expressing HSP72 small interfering RNA reduces cellular levels of HSP72 and significantly exacerbates the heat-induced hypothalamic cell apoptosis and injury. The beneficial effects of mild heat preconditioning are significantly attenuated by silencing of selected genes and knockdown of HSP72. Our data suggest that prior expression of HSP72 by mild heat preconditioning protects against injury and apoptosis caused by severe heat in primary cultured hypothalamic cells.
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![Six experimental groups: (I) no mild heat preconditioning (MHP^−^) and no hyperthermic injury (HI^−^) (MHP^−^ + HI^−^); (II) no MHP and HI (MHP^−^ + HI^+^); (III) MHP^+^ + HI^+^; (IV) MHP^−^ + HI^+^ + siRNA-HSP72^+^; (V) MHP^+^ + HI^+^ + siRNA-vector^+^; and (VI) MHP^+^ + HI^+^ + siRNA-HSP72^+^. Please see Section [2](#s0010){ref-type="sec"} for the explanations of group abbreviations.](gr1){#f0005}

![Effect of siRNA-HSP72 on cellular levels of HSP72 in different groups of cultured primary cells. A: MHP^−^ control; B: MHP^−^ + siRNA-vector; C: MHP^−^ + siRNA-HSP72. Cellular expression of HSP72 was assessed by Western blot analysis in sham groups of rats with no MHP. The gels presented are representative of results from three separate experiments. Densitometry readings of gel bands represent mean ± SD of three separate experiment. ^\*^*P* \< 0.05 for A vs. C.](gr2){#f0010}

![Effect of mild heat preconditioning (MHP^+^) on cellular expression of HSP72 in different groups of cultured primary cells. I: MHP^−^ + HI^−^; II: MHP^−^ + HI^+^; III: MHP^+^ + HI^+^; IV: MHP^−^ + HI^+^ + siRNA-72; V: MHP^+^ + HI^+^ + siRNA-vector; and VI: MHP^+^ + HI^+^ + siRNA-HSP72. Please see Section [2.9](#s0055){ref-type="sec"} procedures for the explanations of the abbreviation. Cellular expression of HSP72 was assessed by Western blot analysis. The gels presented are representative of results from three separate experiments. Densitometry readings of gel bands expressed as arbitrary units of relative intensities to that of MHP^−^ + HI^−^ control. Values represent mean ± SD of three separate experiments. ^\*^*P* \< 0.01 for III vs. II; ^+^*P* \< 0.01 for IV vs. II; ^\#^*P* \< 0.01 for VI vs. III.](gr3){#f0015}

![The percentage of cell viability exhibited in different groups of cultured primary cells. Cells were stained with an MTT assay. Data were presented that MHP^+^ increased the percentage of cell viability during HI^+^ treatment, showed at (A) quality and (B) quantity. In contrast, siRNA-HSP72 exacerbated HI-induced cell death. The beneficial effects of MHP in reducing HI-induced cell death were attenuated by siRNA-HSP72 preconditioning but not by siRNA-vector preconditioning. ^\*^*P* \< 0.001 for II vs. I; ^+^*P* \< 0.05 for II vs. III or for IV vs. II; ^\#^*P* \< 0.05 for VI vs. III. Data are the mean ± SD of triplicate experiments. Please see Section [2.9](#s0055){ref-type="sec"} procedure for the explanations of group abbreviation.](gr4){#f0020}

![The level or apoptosis exhibited in different groups of cultured primary cells. Apoptotic cells were detected on a propidium iodide (PI) histogram as percentage of sub G1 population (A). The percentage of apoptotic cells was determined by flow cytometry after PI labeling. (B) Data are the mean ± SD of triplicate experiments. ^\*^*P* \< 0.01 for II vs. I; ^+^*P* \< 0.05 for III vs. II or for IV vs. II; ^\#^*P* \< 0.01 for VI vs. III. In (A) panel, the data are reported as a representative experiment. Apoptotic cells are characterized by low DNA stain ability and appear below the GI peak in the distribution. Please see Section [2.9](#s0055){ref-type="sec"} procedures for the explanations of group abbreviation.](gr5){#f0025}
